Literature DB >> 11693507

Impact of the Australian Measles Control Campaign on immunity to measles and rubella.

G L Gilbert1, R G Escott, H F Gidding, F M Turnbull, T C Heath, P B McIntyre, M A Burgess.   

Abstract

To evaluate the impact of the 1998 Australian Measles Control Campaign on immunity to measles and rubella, 4400 opportunistically-collected sera, submitted to diagnostic laboratories across Australia from subjects aged 1-49 years, and 3000 from subjects aged 1-18 years, were tested before and after the campaign, respectively. The proportion of individuals aged 1-18 years who were immune to measles rose from 85% before, to 90% after, the campaign (P < 0.001). The greatest increase was in preschool (7%, P < 0.001) and primary school (10%, P < 0.001) children, who were actively targeted by the campaign. Rubella immunity in 1-18 year-olds rose from 83% to 91% (P < 0.0001), again with significant increases in preschool (4%, P = 0.002) and primary school (16%, P < 0.001) children. 94% of individuals aged 19-49 years were immune to rubella. These serosurveys confirm other evidence of the effectiveness of the Australian Measles Control Campaign and demonstrate the value of serosurveillance using opportunistically collected sera.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11693507      PMCID: PMC2869749          DOI: 10.1017/s0950268801005830

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  11 in total

Review 1.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

2.  Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus.

Authors:  J L Backhouse; H F Gidding; P B McIntyre; G L Gilbert
Journal:  Clin Vaccine Immunol       Date:  2006-07

3.  National serosurvey of cytomegalovirus in Australia.

Authors:  Holly Seale; C Raina MacIntyre; Heather F Gidding; J L Backhouse; Dominic E Dwyer; Lyn Gilbert
Journal:  Clin Vaccine Immunol       Date:  2006-09-06

4.  Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.

Authors:  A Tischer; N Andrews; G Kafatos; A Nardone; G Berbers; I Davidkin; Y Aboudy; J Backhouse; C Barbara; K Bartha; B Bruckova; A Duks; A Griskevicius; L Hesketh; K Johansen; L Jones; O Kuersteiner; E Lupulescu; Z Mihneva; M Mrazova; F De Ory; K Prosenc; F Schneider; A Tsakris; M Smelhausova; R Vranckx; M Zarvou; E Miller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

5.  Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.

Authors:  Manoj V Murhekar; Nivedita Gupta; Alvira Z Hasan; Muthusamy Santhosh Kumar; V Saravana Kumar; Christine Prosperi; Gajanan N Sapkal; Jeromie Wesley Vivian Thangaraj; Ojas Kaduskar; Vaishali Bhatt; Gururaj Rao Deshpande; Ullas Padinjaremattathil Thankappan; Avi Kumar Bansal; Sanjay L Chauhan; Gangandeep Singh Grover; Arun Kumar Jain; Ragini N Kulkarni; Santanu Kumar Sharma; Itta K Chaaithanya; Sanchit Kharwal; Sunil K Mishra; Neha R Salvi; Sandeep Sharma; Nilanju P Sarmah; R Sabarinathan; Augustine Duraiswamy; D Sudha Rani; K Kanagasabai; Abhishek Lachyan; Poonam Gawali; Mitali Kapoor; Arpit Kumar Shrivastava; Saurabh Kumar Chonker; Bipin Tilekar; Babasaheb V Tandale; Mohammad Ahmad; Lucky Sangal; Amy Winter; Sanjay M Mehendale; William J Moss; Kyla Hayford
Journal:  Lancet Glob Health       Date:  2022-11       Impact factor: 38.927

Review 6.  Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.

Authors:  Megan K Young; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2013-06-19       Impact factor: 3.452

7.  Lack of immunity against rubella among Italian young adults.

Authors:  Maria Serena Gallone; Cinzia Germinario
Journal:  BMC Infect Dis       Date:  2017-03-07       Impact factor: 3.090

8.  Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination.

Authors:  Amy K Winter; Micaela E Martinez; Felicity T Cutts; William J Moss; Matt J Ferrari; Amalie McKee; Justin Lessler; Kyla Hayford; Jacco Wallinga; C Jess E Metcalf
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

9.  Progress Toward Rubella Elimination - Western Pacific Region, 2000-2019.

Authors:  Jennifer K Knapp; Kayla M Mariano; Roberta Pastore; Varja Grabovac; Yoshihiro Takashima; James P Alexander; Susan E Reef; José E Hagan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-19       Impact factor: 17.586

10.  Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.

Authors:  Heath A Kelly; Heather F Gidding; Theo Karapanagiotidis; Jennie A Leydon; Michaela A Riddell
Journal:  BMC Public Health       Date:  2007-06-08       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.